Skip to content

Clinical trials

Phase 2 Cognition Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognition Disorders Phase: Phase 2 Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20065
20072
20091
20103
20122
20131
20141
20151
20161
20171
20182
20192
20203
20211
20232
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated5
Unknown status4
Recruiting3
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Washington3
National Institute of Mental Health (NIMH)2
University of Pennsylvania2
Wake Forest University Health Sciences2
Antonia New1
AstraZeneca1
Birte Glenthoj1
Brain and Cognition Discovery Foundation1
Center for Neurological Studies1
Cerecin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognition Disorders37
Cognitive Dysfunction14
Alzheimer Disease5
Schizophrenia5
Fatigue4
Mental Disorders4
Brain Diseases3
HIV Infections3
Nervous System Diseases3
Neurocognitive Disorders3

Trials

Showing 76 to 37 of 37. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.